 | |||||
| cannabidiol for epilepsy | |||||
| NEWS | |||||
| Jazz Pharmaceuticals to buy cannabis drugmaker GW Pharmaceuticals for $7.2 billion GW sells a medication called Epidiolex for children with severe epilepsy that ... The drug's active compound, cannabidiol, produces an anticonvulsant ...
| |||||
| Jazz agrees $7.2bn deal to buy cannabis meds pathfinder GW Pharma Jazz Pharma has agreed a $7.2 billion deal to by GW Pharmaceuticals and its pioneering cannabis-derived medicines, headed by childhood epilepsy ...
| |||||
| Marijuana Stocks Rally As Jazz Pharma Agrees To Buy CBD Maker, Senate Majority Leader ... The FDA in 2018 approved the medication to treat rare forms of epilepsy, making it the agency's first approval for a cannabis-derived drug. GW Pharma ...
| |||||
| Jazz Moves to Snap Up Cannabinoid Company, Bolster Neurology Pipeline ... Epidiolex, a cannabinoid approved in the U.S. and Europe for seizures in ... a non-psychoactive cannabis extract, in Phase II testing for epilepsy and ...
| |||||
| Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth ... The company's lead product, Epidiolex® (cannabidiol) oral solution, is approved in patients one-year and older for the treatment of seizures ...
| |||||
| Jazz Pharma to acquire rival for $7.2bn It is perhaps best known for a cannabis-based epilepsy treatment called ... The drug's active compound, cannabidiol, produces an anticonvulsant ...
| |||||
| Dr Pot pots £66m: It's high stakes as cannabis medicine pioneer sells GW Pharmaceuticals for £5.3 ... GW then received approval in the US for a second drug, called Epidyolex, which combats seizures suffered by people with epilepsy. Approval in Europe ...
| |||||
| Medical cannabis developer GW Pharma agrees $7.2bn takeover by Jazz ... later when America's Food and Drug Administration approved its lead product, Epidiolex, a cannabis-based treatment for severe childhood epilepsy.
| |||||
| David Beckham invests in synthetic cannabis company that makes athletic recovery products Some cannabis-based products are also available on prescription for severe epilepsy, nausea caused by chemotherapy and spasms caused by ...
| |||||
| British tycoon dubbed 'Dr Pot' sells cannabis business for whopping £5.3billion It is the first company to be given approval by US authorities for a cannabidiol therapy used for treating seizures in both children and adults.
| |||||
| See more results | Edit this alert | |||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
